The orthotopic lung cancer model was consistent with the results of the subcutaneous tumor model, the antitumor effect of cisplatin was attenuated in p53-mutant and drug-resistant cells, whereas FP NPs were unaffected. The gene discussed is TP53; the disease is lung carcinoma.